Home

We partner with early stage ventures to build companies that transform lives and industries.

About Us

Since 1962, Elron has been at the forefront of Israeli innovation, as founders and early investors in companies such as Elbit Systems, Elscint, Zoran, Partner, Netvision and Given Imaging.

Today we remain committed to our vision of identifying transformative technologies, nurturing gifted entrepreneurs, and building companies into technology leaders.

Our team is dedicated to attracting and supporting imaginative and focused entrepreneurs and startups with never-been-done-before ideas. Group companies benefit from our combined technological, strategic, entrepreneurial & business expertise, broad networks, and wide attention span.

A word from our founder

Where We Invest

We invest in exceptional ideas and technologies with the potential to transform or create new markets, and help make the world a more secure place to live in. We seek investment opportunities from seed to growth stages.
We invest in software with the potential to transform enterprises by providing the means for achieving leaps in scale and efficiency, through automation and speed. We seek investment opportunities from seed to growth stages.
We currently have significant holdings in treatment-changing (rather than treatment-enhancing) medical device companies that are ripe for maturation.

RDC

Strategic JV

RDC was founded in 1993 by Elron and Rafael, a global leader of defense technologies and one of Israel's largest defense companies. RDC combines Rafael's scale and technological edge, with Elron's vast expertise in helping startups develop into leading tech companies.

Through RDC, which has exclusive rights to adapt Rafael's defense technologies for civilian markets, we initiate and develop new companies, and provide essential support from start to exit.

Since its inception, RDC has successfully invested in numerous hi-tech companies. A prime example of RDC's active end-to-end involvement in the growth of its companies is Given Imaging. Given Imaging redefined gastrointestinal disease diagnosis by developing the PillCam ingestible video capsule, based on a unique technology initially invented for military purposes. After becoming a world leader in its field, Given Imaging was acquired for $1 billion.

Our People

Meet our team
 

How We Invest

We aim high.

We invest primarily in early stage ventures with significant exit potential, in which we seek significant shareholder stakes, enabling us to provide hands-on support and contribute from our experience.

We become involved.

We play a defining role in the development of our group companies, by means of active involvement in all aspects of their business and day-to-day operations, to help them reach their long-term objectives.

We are committed.

As an operational holding company that invests its own capital in new and existing group companies, we have the flexibility to support the growth of our group companies over the long term, weather setbacks, and maximize exit events.

Key Stats

$ 0b

value of exit transactions since 2010

$ 0m

investments since 2010

$ 0m

dividends distributed since 2010

0

M&As since 2010

$ 0m

total amount invested in current group companies

News

More news

AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials

February 23, 2021

The technology could set new standards for data enrichment and patient-centric conduct of clinical trials

Read More

IRONSCALES Wins Several Best-Of Honors at the Expert Insights Cybersecurity Awards

February 17, 2021

The company is proud to be recognized in multiple “Best-Of” awards from Expert Insights in the categories of Email Security Gateway, Post-Delivery Protection, Phishing Protection and Security Awareness Training

Read More

IRONSCALES New Product Release Strengthens Advanced Phishing Threat Detection Capabilities to Mitigate Account Takeover and Credential Harvesting

February 1, 2021

IRONSCALES announced new platform features as part of its new release to further improve the company’s ability to detect advanced and highly targeted phishing attacks

Read More
More news